Psychological and Nutritional Considerations The appetite-suppressing power of semaglutide might lead some to rely too heavily on it, potentially fostering poor eating habits and body image issues
To maintain their lead, Novo and Eli Lilly are also working on next-generation treatments, targeting some of the same gaps in the marketplace
Tirzepatide is a dual GIP and GLP-1 receptor agonist, hitting two pathways simultaneously
A consultation can review the symptom you want to address, more established explanations and treatments, product sourcing, route options, potential interactions, and whether an elective IV is a reasonable choice
Only use a Neti pot with safe water Water can contain tiny germs that may cause a deadly brain infection
Pregnant, breastfeeding, or kidney/liver patients should avoid this treatment